BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/14/2020 12:33:31 PM | Browse: 633 | Download: 1026
 |
Received |
|
2020-03-13 06:13 |
|
Peer-Review Started |
|
2020-03-13 06:19 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-04-25 15:28 |
|
Revised |
|
2020-07-02 07:49 |
|
Second Decision |
|
2020-07-03 07:44 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-07-04 04:10 |
|
Articles in Press |
|
2020-07-04 04:10 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-07-16 06:02 |
|
Typeset the Manuscript |
|
2020-08-14 01:19 |
|
Publish the Manuscript Online |
|
2020-08-14 12:33 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Microbiology |
| Manuscript Type |
Review |
| Article Title |
Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Bei Yue, Zhi-Lun Yu, Cheng Lv, Xiao-Long Geng, Zheng-Tao Wang and Wei Dou |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81273572 |
| National Natural Science Foundation of China |
81530096 |
| Natural Science Foundation of Shanghai |
17ZR1427800 |
|
| Corresponding Author |
Wei Dou, PhD, Professor, Shanghai Key Laboratory of Formulated Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, No. 1200, Cailun Road, Pudong New Area, Shanghai 201203, China. douwei123456@126.com |
| Key Words |
Inflammatory bowel disease; Pro/Prebiotics; Fecal microbiota transplantation; Herbal medicines; Clinical application; |
| Core Tip |
In this review, we explore therapies targeting intestinal microbiota, such as fecal bacteria transplantation, pro/prebiotics, and herbal medicinal products, that represent effective therapeutic options to control and slow the progression of inflammatory bowel disease (IBD). We additionally discuss some challenges and controversies in relation to these emerging therapeutic strategies. It has direct inspiration on researchers to overcome the current limitations of IBD therapies and shed light on personalized treatment options. |
| Publish Date |
2020-08-14 12:33 |
| Citation |
Yue B, Yu ZL, Lv C, Geng XL, Wang ZT, Dou W. Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease. World J Gastroenterol 2020; 26(30): 4378-4393 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i30/4378.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i30.4378 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
